NSCLC, STAGE I
Clinical trials for NSCLC, STAGE I explained in plain language.
Never miss a new study
Get alerted when new NSCLC, STAGE I trials appear
Sign up with your email to follow new studies for NSCLC, STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug stop early lung cancer from returning?
Disease control Recruiting nowThis study looks at whether giving the drug pembrolizumab after surgery can help prevent stage I non-small cell lung cancer from returning. About 244 people who had their tumor removed will be randomly assigned to receive either pembrolizumab infusions every 6 weeks for about a y…
Matched conditions: NSCLC, STAGE I
Phase: PHASE2 • Sponsor: Greg Durm, MD • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New combo aims to shield scarred lungs from radiation damage
Disease control Recruiting nowThis study tests whether adding BIO 300 to standard chest radiation can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease (lung scarring). About 25 adults will receive the combination and b…
Matched conditions: NSCLC, STAGE I
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC